A Study of LY3405105 in Participants With Advanced Cancer

J1F-MC-JZFA -

The main purpose of this study is to investigate the safety of LY3405105 in participants with advanced cancer. The study has two parts phase 1a and phase 1b. Participants will only enroll in one part.

Trial Summary

Age Range
≥18 years
Conditions the trial is for
What the trial is testing?
Could I receive a Placebo?
No
Enrollment Goal
54
Trial Dates
Jan 31, 2019 - Feb 4, 2021
How long will I be in the trial?
Your participation in this trial could last 6 months or longer depending on how you and your tumor respond.
Trial Phase
I

Lilly Trial Alerts

Not the right fit? Sign up to receive updates about new trials that are listed or when a new trial site begins enrolling near you.